Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Nxera Pharma - Nxera Pharma to Receive US$3.6 Million in Milestone Payment Pursuant to Research Collaboration with Centessa
Nxera Pharma to Receive US$3.6 Million in Milestone Payment Pursuant to Research Collaboration with Centessa
GlobeNewswire

Tokyo, Japan and Cambridge, UK, 13 January 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Centessa Pharmaceuticals has achieved an early development milestone associated with its…

thehindubusinessline.com - Indian Pharma Alliance launches PAGE in Gujarat to tackle industry's talent paradox
Indian Pharma Alliance launches PAGE in Gujarat to tackle industry's talent paradox
BusinessLine

Despite churning out thousands of science and pharmacy graduates each year, India's pharmaceutical industry faces a paradox of abundant academic talent but a shortage of job-ready professionals, a gap highlighted by Satish Reddy, Executive Council…

techcrunch.com - Kate Park - Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
TechCrunch

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising cost. More than 200 startups are now competing to…

marketbeat.com - Marshall Urist Sells 20,000 Shares of Royalty Pharma (NASDAQ:RPRX) Stock
Marshall Urist Sells 20,000 Shares of Royalty Pharma (NASDAQ:RPRX) Stock
MarketBeat

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 20,000 shares of the company's stock in a transaction that occurred on Friday, January 9th. The shares were sold at an average price of $40.78, for a total value of…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Stock Price Down 6.7% - Here's What Happened
Urogen Pharma (NASDAQ:URGN) Stock Price Down 6.7% - Here's What Happened
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report) shares dropped 6.7% on Tuesday. The company traded as low as $20.02 and last traded at $20.0130. Approximately 457,916 shares changed hands during mid-day trading, a decline of 15% from the average…

telegraph.co.uk - Simeon Tegel - Amazon healthcare delves deep into the jungle's 'medicine cabinet'
Amazon healthcare delves deep into the jungle's 'medicine cabinet'
The Telegraph

In a wooden shack on stilts overlooking a muddy tributary of the Amazon, the shaman gently lays his palm on the head of his patient, a young woman with back pain. After feeling her “energy”, Ignacio Majipo, 78, gives his patient a pep…

marketbeat.com - NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 6.5% - Time to Sell?
NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 6.5% - Time to Sell?
MarketBeat

Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) were down 6.5% during trading on Monday. The company traded as low as $31.85 and last traded at $32.1190. Approximately 400,035 shares were traded during trading, a decline…

marketbeat.com - BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 40,000 Shares
BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 40,000 Shares
MarketBeat

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 40,000 shares of BridgeBio Pharma stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $73.97, for a total value of $2,958,800.00.

theguardian.com - Peter Bradshaw - 28 Years Later: The Bone Temple review - Ralph Fiennes is phenomenal in best chapter yet of zombie horror
28 Years Later: The Bone Temple review - Ralph Fiennes is phenomenal in best chapter yet of zombie horror
The Guardian

It's very rare for a fourquel to be the best film in a franchise, but that's how things stand with the chequered 28 Days Later series. In this one, which follows immediately on from the previous episode, 28 Years Later, Ralph Fiennes and Jack…

entrepreneur.com - Entrepreneur Store - Make Tax Season a Strategic Win with This Deal on H&R Block Tax Software Deluxe
Make Tax Season a Strategic Win with This Deal on H&R Block Tax Software Deluxe
Entrepreneur

Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from our commerce partners. Tax season isn't exactly…

arstechnica.com - Beth Mole - FDA deletes warning on bogus autism therapies touted by RFK Jr.'s allies
FDA deletes warning on bogus autism therapies touted by RFK Jr.'s allies
Ars Technica

For years, the Food and Drug Administration provided an informational webpage for parents warning them of the dangers of bogus autism treatments, some promoted by anti-vaccine activists and “wellness” companies. The page cited…

deccanchronicle.com - DC Correspondent - DCA Seizes Spurious Levipil 500 Tablets in Quthbullapur
DCA Seizes Spurious Levipil 500 Tablets in Quthbullapur
Deccan Chronicle

Hyderabad: Telangana Drugs Control Administration (DCA) seized spurious drug ‘Levipil 500' tablets (Levetiracetam Tablets 500 mg), falsely claimed to be manufactured by a particular pharma companny. During the raid conducted by the DCA based…

nytimes.com - Andrew Ross Sorkin - The Powell Defense Grows
The Powell Defense Grows
The New York Times

Andrew here. The fallout from the criminal investigation into Jay Powell, the Fed chair, continues. On Monday, I mentioned that the silence from business leaders was conspicuous. Yet several Republican lawmakers have now criticized the Trump…

deccanchronicle.com - Sangeetha G - US Tariff Strike On Iran To Hit India's $1.7 Bn Trade
US Tariff Strike On Iran To Hit India's $1.7 Bn Trade
Deccan Chronicle

Chennai: US President Donald Trump's move to impose additional 25 per cent tariffs on countries trading with Iran can affect India's $1.7 trade with the Middle East country. While exporters are experiencing slower demand due to internal conflict…

siliconangle.com - Kyt Dotson - Converge Bio raises $25M to accelerate drug discovery using generative AI solutions
Converge Bio raises $25M to accelerate drug discovery using generative AI solutions
SiliconANGLE

Accelerated drug discovery and development platform Converge Bio Inc. today announced it raised $25 million in Series A funding to develop better drugs for pharmaceutical companies and open up opportunities in the industry using artificial…

Receive a Daily briefing on Pharma Industry News

Get Started